The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Open accessAbstract
In acute myeloid leukaemia (AML), the cell of origin, nature and biological consequences of initiating lesions, and order of subsequent mutations remain poorly understood, as AML is typically diagnosed without observation of a pre-leukaemic phase. Here, highly purified haematopoietic stem cells (HSCs), progenitor and mature cell fractions from the blood of AML patients were found to contain recurrent DNMT3A mutations (DNMT3A(mut)) at high allele frequency, but without coincident NPM1 mutations (NPM1c) present in AML blasts. DNMT3A(mut)-bearing HSCs showed a multilineage repopulation advantage over non-mutated HSCs in xenografts, establishing their identity as pre-leukaemic HSCs. Pre-leukaemic HSCs were found in remission samples, indicating that they survive chemotherapy. Therefore DNMT3A(mut) arises early in AML evolution, probably in HSCs, leading to a clonally expanded pool of pre-leukaemic HSCs from which AML evolves. Our findings provide a paradigm for the detection and treatment of pre-leukaemic clones before the acquisition of additional genetic lesions engenders greater therapeutic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies in patients with AML have confirmed the functional importance and clinical significance of preleukemic stem cell populations as the cellular origin of leukemia-initiating cells in human disease27, 48.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DNMT3A is also recurrently mutated in blood diseases such as acute myeloid leukemia (AML; ref. 9) and myelodysplastic syndromes (MDS; ref. 10) where it functions as an initiating mutation (11).”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“In later studies, DNA sequencing of HSCs from AML patients in remission revealed that stem cells with only a single driver mutation were often present, suggesting that pre-malignant clonal hematopoiesis was a generalizable finding in AML 23–25.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,084
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H. F., Sun, Z., Racevskis, J., Vlierberghe, P. V., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,990
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Cao, S., Wang, Q., & Zhu, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094005 · Cited by 15
Hematopoiesis during development, aging, and disease
Jung, J., Buisman, S. C., & de Haan, G. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.05.007 · Cited by 10
Yao, W.-L., Wen, Q., Zhao, H.-Y., Tang, S.-Q., Zhang, Y.-Y., Wang, Y., Xu, L.-P., Zhang, X.-H., Huang, X.-J., & Kong, Y. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13531 · Cited by 10
Research progress on molecular biomarkers of acute myeloid leukemia
Yin, P.-Y., Wang, R.-W., Jing, R., Li, X., Ma, J., Li, K., & Wang, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1078556 · Cited by 10
Dong, Y., Jin, F., Wang, J., Li, Q., Huang, Z., Xia, L., & Yang, M. (2023) · Current Gene Therapy · doi:10.2174/1566523223666230724121515 · Cited by 11
Self-citationCellular origin of prognostic chromosomal aberrations in AML patients
Mora-Jensen, H. I., Jendholm, J., Rapin, N., Andersen, M. K., Roug, A. S., Bagger, F. O., Bullinger, L., Winther, O., Borregaard, N., Porse, B. T., et al. (2015) · Leukemia · doi:10.1038/leu.2015.30 · Cited by 10
Reikvam, H., Hoang, T., & Bruserud, Ø. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.1036025 · Cited by 10
Tan, Y., Liu, H., & Chen, S. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0423-x · Cited by 10
Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD
Chien, W., Sun, Q.-Y., Ding, L.-W., Mayakonda, A., Takao, S., Liu, L., Lim, S. L., Tan, K. T., Garg, M., Varela, A. D. S. M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.343 · Cited by 10
Knorr, K. L. B., Finn, L. E., Smith, B. D., Hess, A. D., Foran, J. M., Karp, J. E., & Kaufmann, S. H. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0034 · Cited by 10
CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion
Jin, C., Li, Y., Xia, J., Li, Y., Chen, M., Hu, Z., Mapara, M. Y., Li, W., & Yang, Y. (2018) · American Journal of Hematology · doi:10.1002/ajh.25099 · Cited by 10
Čulen, M., Košářová, Z., Ježíšková, I., Folta, A., Chovancová, J., Loja, T., Tom, N., Bystrý, V., Janečková, V., Dvořáková, D., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2652-2 · Cited by 10
Flach, J., Shumilov, E., Wiedemann, G., Porret, N. A., Shakhanova, I., Bürki, S., Legros, M., Joncourt, R., Pabst, T., & Bacher, U. (2020) · Hematological Oncology · doi:10.1002/hon.2739 · Cited by 10
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Shlush, L. I., & Feldman, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13236 · Cited by 10
Self-citationClonal haematopoiesis of emerging significance
Hammond, D. E., & Loghavi, S. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.005 · Cited by 10
Jin, H., Zhu, Y., Hong, M., Wu, Y., Qiu, H., Wang, R., Jin, H. Z., Sun, Q., Fu, J., Li, J., et al. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1919660 · Cited by 10
Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesis
Shallis, R. M., & Gore, S. D. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2034156 · Cited by 10
The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia
Li, Q., Wang, M., & Liu, L. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115539 · Cited by 11
Mancini, M., Hasan, S. K., Ottone, T., Lavorgna, S., Ciardi, C., Angelini, D. F., Agostini, F., Venditti, A., & Lo‐Coco, F. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.10.003 · Cited by 10
Controlling Pre-leukemic Thymocyte Self-Renewal
Goossens, S., & Vlierberghe, P. V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004881 · Cited by 10
Pettersson, L., Chen, Y., George, A. M., Rigo, R., Lazarević, V., Juliusson, G., Saal, L. H., & Ehinger, M. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1755855 · Cited by 10
A Review of Complex Systems Approaches to Cancer Networks
Uthamacumaran, A. (2020) · Complex Systems · doi:10.25088/complexsystems.29.4.779 · Cited by 10
Nonrandom chromosome abnormalities in cancer
Heim, S., & Mitelman, F. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch4 · Cited by 10
Nam, A. S., Dusaj, N. N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M. R., Gaiti, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.14.476225 · Cited by 10
Proliferation: Driver of HSC aging phenotypes?
Yanai, H., & Beerman, I. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111331 · Cited by 9
Simoes, C. P., Chillón, C., Martínez‐Cuadrón, D., Calasanz, M. J., Vridiales, M.-B., Vázquez, I., Hernández-Ruano, M., Ariceta, B., Aguirre‐Ruiz, P., Burgos, L., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008141 · Cited by 9
Tespa1 facilitates hematopoietic and leukemic stem cell maintenance by restricting c-Myc degradation
Lu, Y., Yang, L., Shen, M., Zhang, Z., Wang, S., Chen, F., Chen, N., Xu, Y., Zeng, H., Chen, M., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01880-6 · Cited by 9
Self-citationTecik, M., & Adan, A. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01202-7 · Cited by 9
Recent advances in AML with mutated NPM1
Ishikawa, Y., Ushijima, Y., & Kiyoi, H. (2024) · International Journal of Hematology · doi:10.1007/s12185-024-03835-8 · Cited by 9
Cancer stem cells: Masters of all traits
Leck, L. Y. W., El-Aziz, Y. S. A., McKelvey, K. J., Park, K. C., Sahni, S., Lane, D. J. R., Skoda, J., & Jansson, P. J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167549 · Cited by 9
Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope
Bao, J., Freund, O., Sund, L., & Du, W. (2026) · Cells · doi:10.3390/cells15040338 · Cited by 15
DNMT3A mutation analysis in adult patients with acute lymphoblastic leukemia
Liu, Y., Zhang, N., Wu, Y., Yang, L., Ding, X., Zhou, J., & Xiao, M. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1434-1 · Cited by 9
Acute Myeloid Leukemia: How Do We Measure Success?
Sasine, J. P., & Schiller, G. J. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0346-x · Cited by 9
Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies
Czegle, I., Gray, A. L., Wang, M., Liu, Y., Wang, J., & Wappler-Guzzetta, E. A. (2021) · Life · doi:10.3390/life11121351 · Cited by 10
Self-citationGupta, S., Dovey, O. M., Domingues, A. F., Cyran, O. W., Cash, C. M., Giotopoulos, G., Rak, J. M., Cooper, J. L., Gozdecka, M., Dijkhuis, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn4886 · Cited by 10
Donato, E., Correia, N., Andresen, C., Karpova, D., Würth, R., Klein, C., Sohn, M., Przybylla, A., Zeisberger, P., Rothfelder, K., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008497 · Cited by 11
Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway
Palam, L. R., Ramdas, B., Pickerell, K., Pasupuleti, S. K., Kanumuri, R., Cesarano, A., Szymanski, M., Selman, B., Davé, U. P., Sandusky, G. E., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.163864 · Cited by 9
Bae, S.-G., Kim, H., Kim, M. Y., Kim, D. H., Shin, S.-I., Ahn, J., & Park, J. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0093 · Cited by 9
Self-citationWang, B., Li, Y., & Yu, L. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.163400 · Cited by 9
Tumor Archaeology: Tracking Leukemic Evolution to Its Origins
Dick, J. E. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009168 · Cited by 9
Self-citationBCR/ABL can promote CD19+ cell growth but not render them long-term stemness
Li, D., Zhao, X., Zhang, R., Jiao, B., Liu, P., & Ren, R. (2016) · Stem Cell Investigation · doi:10.21037/sci.2016.11.06 · Cited by 9
Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia
Chen, S., Hu, F., Wang, D., Qin, Z.-Y., Liang, Y., & Dai, Y. (2020) · Aging · doi:10.18632/aging.103357 · Cited by 9
Induced pluripotent stem cell models of myeloid malignancies and clonal evolution
Reilly, A., & Doulatov, S. R. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102195 · Cited by 9
Tan, G., & Meier‐Abt, F. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.02.011 · Cited by 9
Heini, A. D., Porret, N. A., Zenhäusern, R., Winkler, A., Bacher, U., & Pabst, T. (2021) · Cancers · doi:10.3390/cancers13133190 · Cited by 9
Baba, Y., Saito, B., Shimada, S., Sasaki, Y., Fujiwara, S., Arai, N., Kawaguchi, Y., Kabasawa, N., Tsukamoto, H., Uto, Y., et al. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03187-7 · Cited by 10
Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia
Lu, J., Chen, M., Hua, H., Qin, W., Zhang, R., Lu, X., & Chao, H. (2021) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13648 · Cited by 9
TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Rahmé, R., Braun, T., Manfredi, J. J., & Fenaux, P. (2023) · Biomedicines · doi:10.3390/biomedicines11041152 · Cited by 9
Base Editor Scanning Reveals Activating Mutations of DNMT3A
Garcia, E. M., Lue, N. Z., Liang, J. K., Lieberman, W. K., Hwang, D. D., Woods, J. C., & Liau, B. B. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00257 · Cited by 9
Novel methods and approaches to acute lymphoblastic leukemia drug discovery
Wei, M. C., & Cleary, M. L. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.956720 · Cited by 9
Metastatic-initiating cells and lipid metabolism
Benitah, S. A. (2017) · Cell Stress · doi:10.15698/cst2017.12.113 · Cited by 11
NPM1 Biology in Myeloid Neoplasia
Patel, S. S., Kluk, M., & Weinberg, O. K. (2020) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-020-00592-3 · Cited by 10
The Intriguing Clinical Success of BCL-2 Inhibition in Acute Myeloid Leukemia
Pollyea, D. A., Pei, S., Stevens, B. M., Smith, C. A., & Jordan, C. T. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060220-124048 · Cited by 9
Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells
Lewis, A. H., Bridges, C. S., Punia, V. S., Cooper, A. F. J., Puppi, M., & Lacorazza, H. D. (2021) · Oncotarget · doi:10.18632/oncotarget.27878 · Cited by 9
Pathobiology of Acute Myeloid Leukemia
Brunner, A. M., & Graubert, T. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00058-5 · Cited by 9
Bolouri, H., Farrar, J. E., Triche, T., Ries, R. E., Lim, E. L., Alonzo, T. A., Ma, Y. P., Moore, R., Mungall, A. J. J., Marra, M. A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/125609 · Cited by 9
The evolutionary dynamics and fitness landscape of clonal haematopoiesisPreprint
Watson, C. J., Papula, A., Poon, Y. P. G., Wong, W., Young, A. L., Druley, T. E., Fisher, D. S., & Blundell, J. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/569566 · Cited by 9
Gaiti, F., Chamely, P., Hawkins, A. G., Cortés-López, M., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C. Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495292 · Cited by 9
Sperotto, A. A., Bochicchio, M. T., Simonetti, G., Buccisano, F., Peccatori, J., Piemontese, S., Calistri, E., Ciotti, G., Pierdomenico, E., Marchi, R. D., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020359 · Cited by 8
Cerella, C., Gajulapalli, S. R., Lorant, A., Gérard, D., Muller, F., Lee, Y., Kim, K. R., Han, B. W., Christov, C., Récher, C., et al. (2023) · Leukemia · doi:10.1038/s41375-023-02076-8 · Cited by 8
Tao, Y., Ran, B., Wang, J., Hu, Q., Wen, Y., Qiu, Q., & Niu, T. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115579 · Cited by 8
Self-citationKamath, A. M., Ternes, S., McGowan, S. E., & Moy, A. B. (2018) · Regenerative Medicine · doi:10.2217/rme-2018-0041 · Cited by 8
Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation
Jin, X., Ng, V., Zhao, M., Liu, L., Higashimoto, T., Lee, Z. H., Chung, J., Chen, V., Ney, G. M., Kandarpa, M., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049088 · Cited by 8
Clonal Hematopoiesis: Origins and determinants of evolution
Mendez, L., & Patnaik, M. M. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107076 · Cited by 8
On the Origin of Leukemic Species
Vasanthakumar, A., & Godley, L. A. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.03.008 · Cited by 8
Epigenetic deregulation in myeloid malignancies
Meldi, K. M., & Figueroa, M. E. (2014) · Translational research · doi:10.1016/j.trsl.2014.04.012 · Cited by 9
Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia
Mosna, F., & Gottardi, M. (2016) · Stem Cells International · doi:10.1155/2016/7625827 · Cited by 8
Stem Cells Cycle toward Immune Surveillance
Boyd, A. S., & Rodrigues, N. P. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.006 · Cited by 8
Humanised mouse models for haematopoiesis and infectious diseases
Lysenko, V., McHugh, D., Behrmann, L., Rochat, M.-A., Wilk, C. M., Kovtonyuk, L. V., Bourquin, J., Münz, C., Manz, M. G., Speck, R. F., et al. (2017) · Swiss Medical Weekly · doi:10.4414/smw.2017.14516 · Cited by 8
Gabay, T. S., Chapal-Ilani, N., Moskovitz, Y., Biezuner, T., Oron, B., Brilon, Y., Fridman‐Dror, A., Sabah, R., Balicer, R. D., Tanay, A., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.242347 · Cited by 9
Self-citationMa, J., Wen, X.-M., Xu, Z., Xia, P., Ye, J., Lin, J., & Qian, J. (2022) · Current Oncology · doi:10.3390/curroncol29090525 · Cited by 8
Single Cell Transcriptomics to Understand HSC Heterogeneity and Its Evolution upon Aging
Hérault, L., Poplineau, M., Rémy, É., & Duprez, E. (2022) · Cells · doi:10.3390/cells11193125 · Cited by 9
Bohnenberger, H., Ströbel, P., Mohr, S., Corso, J., Berg, T., Urlaub, H., Lenz, C., Serve, H. L., & Oellerich, T. (2015) · Journal of Visualized Experiments · doi:10.3791/52435 · Cited by 8
Hassan, S., & Smith, M. (2014) · Hematology · doi:10.1179/1024533214z.000000000312 · Cited by 9
Kikushige, Y., & Miyamoto, T. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1740-1 · Cited by 8
Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia
Reuter, C. W., Krauter, J., Onono, F. O., Bunke, T., Damm, F., Thol, F. R., Wagner, K., Göhring, G., Schlegelberger, B., Heuser, M., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2061-9 · Cited by 8
MDS-related mutations in aplastic anemia
Ogawa, S. (2014) · Blood · doi:10.1182/blood-2014-09-597708 · Cited by 8
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications
Malcovati, L., Ambaglio, I., & Elena, C. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000229 · Cited by 8
Incidence of preleukemic fusion genes in healthy subjects
KOSIK, P., Škorvaga, M., & Belyaev, I. Y. (2016) · Neoplasma · doi:10.4149/neo_2016_502 · Cited by 8
Single‐cell analyses to reveal hematopoietic stem cell fate decisions
Lunger, I., Fawaz, M., & Rieger, M. A. (2017) · FEBS Letters · doi:10.1002/1873-3468.12712 · Cited by 9
Vicario, M., Mattiolo, A., Montini, B., Piano, M. A., Cavallari, I., Amadori, A., Chieco‐Bianchi, L., & Calabrò, M. L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01215 · Cited by 8
Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias
Huang, B. J., Wandler, A. M., Meyer, L. K., Dail, M., Daemen, A., Sampath, D., Li, Q., Wang, X., Wong, J. C. Y., Nakitandwe, J., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008168 · Cited by 8
Transposable elements shape stemness in normal and leukemic hematopoiesis
Grillo, G., Nadorp, B., Qamra, A., Drylie, B., Mitchell, A., Arlidge, C., Nand, A., Takayama, N., Murison, A., Tonekaboni, S. A. M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02585-z · Cited by 11
Self-citationLao, Z., Ding, L., Sun, Q.-Y., Li, J., Yan, B., Ng, A. Y. J., Capinpin, S. M., Wang, R., Li, Y., Chng, W. J., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3804 · Cited by 7
RNA binding protein‐directed control of leukemic stem cell evolution and function
Joshi, P., Chahi, A. K., Liu, L., Moreira, S., Vujovic, A., & Hope, K. J. (2024) · HemaSphere · doi:10.1002/hem3.116 · Cited by 9
Yao, S., Guo, R., Tian, W., Zheng, Y., Hu, J. J., Han, G., Yin, R., Zhou, F., & Zhang, H. (2024) · Blood Science · doi:10.1097/bs9.0000000000000206 · Cited by 7
Mosialou, I., Ali, A. M., Labella, R., Bisikirska, B. C., Cuesta‐Domínguez, Á., Vgenopoulou, P., Reyes, I., Rao, S. M., Wang, A., Luo, N., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.007 · Cited by 8
Resolving leukemic stem cell heterogeneity and plasticity with single-cell multiomics
Huang, F. Y., Trumpp, A., & Stelmach, P. (2025) · Seminars in Hematology · doi:10.1053/j.seminhematol.2025.07.001 · Cited by 7
Nann, D., Schade, T., Overkamp, M., Mahmutovic, L., Bag, E., Forchhammer, S., Slotta‐Huspenina, J., Boudová, L., Sotlar, K., Quintanilla‐Martínez, L., et al. (2025) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.70044 · Cited by 7
Tan, G., Wolski, W., Kummer, S., Hofstetter, M., Theocharides, A. P. A., Manz, M. G., Aebersold, R. H., & Meier‐Abt, F. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021005344 · Cited by 7
Kanellou, P., Georgakopoulos‐Soares, I., & Zaravinos, A. (2023) · Cancers · doi:10.3390/cancers15061795 · Cited by 7
Sandoval, C., Calle, Y., Godoy, K., & Farías, J. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076031 · Cited by 8
Sex-Based Differences in Risk of Therapy-Related Myeloid Neoplasms
Richard, M. A., Yan, C., Chen, Y.-J., Gibson, C. J., Kalra, R., Bosworth, A., Crossman, D. K., Singh, P., Hageman, L., He, J., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco-24-01487 · Cited by 7
Persistence of leukaemic ancestors
Potter, N. E., & Greaves, M. F. (2014) · Nature · doi:10.1038/nature13056 · Cited by 7
Zhang, X., Zhang, Q., Dahlström, J., Tran, A. N., Yang, B., Gu, Z., Ghaderi, M., Porwit‐MacDonald, A., Jia, J., Derolf, Å. R., et al. (2014) · Leukemia · doi:10.1038/leu.2014.113 · Cited by 7
Knorr, K. L. B., & Goldberg, A. D. (2020) · Haematologica · doi:10.3324/haematol.2019.241117 · Cited by 8
An updated account on molecular heterogeneity of acute leukemia.
Rahul, E., Goel, H., Chopra, A., Ranjan, A., Gupta, A., Meena, J. P., Bakhshi, S., Misra, A., Hussain, S., Viswanathan, G. K., et al. (2021) · PubMed Central · Cited by 7
Stem cell concepts in myelodysplastic syndromes: lessons and challenges
Woll, P. S., & Jacobsen, S. E. W. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13283 · Cited by 7
Role of the Bone Marrow Microenvironment in Drug Resistance of Hematological Malignances
Hosseini, A., Hamblin, M. R., Mirzaei, H., & Mirzaei, H. R. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210910124319 · Cited by 7
Kalushkova, A., Nylund, P., Párraga, A. A., Lennartsson, A., & Jernberg‐Wiklund, H. (2021) · Epigenomes · doi:10.3390/epigenomes5040022 · Cited by 7
Metadata
- Authors
- Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., McLeod, J. L., Doedens, M., Medeiros, J. J. F., Marke, R., Kim, H. J., Lee, K., McPherson, J. D., Hudson, T. J., Pan-Leukemia Gene Panel Consortium, T. H., Brown, A. M. K., Yousif, F., Trinh, Q. M., Stein, L. D., Minden, M. D., Wang, J. C. Y., & Dick, J. E.
- Affiliations
- University Health Network (CA)
- Chonnam National University (KR)
- Ontario Institute for Cancer Research (CA)
- Corresponding author
- Dick, John E.
- ORCID
- Venue
- Nature
- Published
- 2014-02-12
- Volume
- 506
- Issue
- 7488
- Pages
- 328-333
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4991939
- OpenAlex
- W2076031927
- Cited by
- 1,443
- References
- 53
- Citations by year
- 2026: 50 · 2025: 48 · 2024: 75 · 2023: 95 · 2022: 94 · 2021: 110 · 2020: 136 · 2019: 131 · 2018: 139 · 2017: 160 · 2016: 153 · 2015: 159 · 2014: 88
- FWCI
- 132.63
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-16)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Hospital for Sick Children
- Canadian Institutes of Health Research (105367_1)
- National Cancer Institute (R21CA152613)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, DNMT3A mutation, NPM1 mutation, clonal evolution, treatment resistance, relapse, clonal expansion, chemotherapy remission, tumor heterogeneity, xenografts, mutation order, hematopoiesis
- MeSH terms
- DNA Methyltransferase 3A, Nucleophosmin, Animals, Cell Differentiation, Cell Division, Clone Cells, DNA (Cytosine-5-)-Methyltransferases, Female, Hematopoiesis, Hematopoietic Stem Cells, Humans, Isocitrate Dehydrogenase, Mutation, Neoplasm Transplantation, Nuclear Proteins, Remission Induction, T-Lymphocytes, Neoplastic Stem Cells, Leukemia, Myeloid, Acute, Mice, SCID, Mice, Inbred NOD, Drug Resistance, Neoplasm, Cell Lineage, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
